Uwe Reuter

19.0k total citations · 9 hit papers
315 papers, 12.4k citations indexed

About

Uwe Reuter is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Uwe Reuter has authored 315 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 201 papers in Psychiatry and Mental health, 110 papers in Pathology and Forensic Medicine and 59 papers in Physiology. Recurrent topics in Uwe Reuter's work include Migraine and Headache Studies (197 papers), Trigeminal Neuralgia and Treatments (100 papers) and Sympathectomy and Hyperhidrosis Treatments (48 papers). Uwe Reuter is often cited by papers focused on Migraine and Headache Studies (197 papers), Trigeminal Neuralgia and Treatments (100 papers) and Sympathectomy and Hyperhidrosis Treatments (48 papers). Uwe Reuter collaborates with scholars based in Germany, United States and Denmark. Uwe Reuter's co-authors include Lars Neeb, Michael A. Moskowitz, Daniel D. Mikol, Messoud Ashina, Robert Lenz, Peter J. Goadsby, Hayrünnisa Bolay, Bianca Raffaelli, David A. Boas and Zhihong Huang and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Uwe Reuter

300 papers receiving 12.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model

2002 912 citations Uwe Reuter et al. profile →
A Controlled Trial of Erenumab for Episodic Migraine

2017 631 citations Uwe Reuter, Feng Zhang et al. profile →
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

2017 538 citations Stewart J. Tepper, Messoud Ashina et al. profile →
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study

2018 332 citations Uwe Reuter, Jan Klatt et al. profile →
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

2019 256 citations Simona Sacco, Messoud Ashina et al. The Journal of Headache and Pain profile →
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

2022 214 citations Simona Sacco, Faisal Mohammad Amin et al. The Journal of Headache and Pain profile →
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial

2023 75 citations Patricia Pozo‐Rosich, Messoud Ashina et al. profile →
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis

2023 63 citations Christian Lampl, Antoinette MaassenVanDenBrink et al. The Journal of Headache and Pain profile →
Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives

2025 18 citations Jan Versijpt, Koen Paemeleire et al. profile →

Peers

Countries citing papers authored by Uwe Reuter

Since Specialization

Citations

This map shows the geographic impact of Uwe Reuter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Reuter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Reuter more than expected).

Fields of papers citing papers by Uwe Reuter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Reuter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Reuter. The network helps show where Uwe Reuter may publish in the future.

Co-authorship network of co-authors of Uwe Reuter

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Reuter. A scholar is included among the top collaborators of Uwe Reuter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Reuter. Uwe Reuter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study 2024 ·The Journal of Headache and Pain ·Marie Süße, (unknown), Sebastian Strauß, Johanna Ruhnau, Lucas Hendrik Overeem, (unknown), Juliane Schulze, Uwe Reuter, Antje Vogelgesang, Robert Fleischmann	10
2	Early Improvements With Atogepant for the Preventive Treatment of Migraine 2024 ·Neurology ·Richard B. Lipton, Pranav Gandhi, Cristina Tassorelli, Uwe Reuter, Andrea M. Harriott, Dagny Holle, Christopher Gottschalk, Brian A. Neel, (unknown), Hua Guo, Jonathan Stokes, Kristóf Nagy, (unknown), (unknown)	1
3	Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies 2023 ·Pharmaceutics ·Bianca Raffaelli, (unknown), (unknown), Kristin Sophie Lange, Jasper Mecklenburg, Lucas Hendrik Overeem, (unknown), (unknown), Uwe Reuter	4
4	Sex Hormones and Calcitonin Gene–Related Peptide in Women With Migraine 2023 ·Neurology ·Bianca Raffaelli, (unknown), Lucas Hendrik Overeem, (unknown), (unknown), Kristin Sophie Lange, Uwe Reuter	34
5	Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis 2023 ·Headache The Journal of Head and Face Pain ·Stewart J. Tepper, Richard B. Lipton, Stephen D. Silberstein, David Kudrow, Messoud Ashina, Uwe Reuter, David W. Dodick, Andrea Wang, Sunfa Cheng, Jan Klatt, Daniel D. Mikol	5
6	The sense of stopping migraine prophylaxis 2023 ·The Journal of Headache and Pain ·Linda Al‐Hassany, Hannah Lyons, Deirdre M. Boucherie, Fatemeh Farham, Kristin Sophie Lange, Karol Marschollek, Dilara Onan, Umberto Pensato, (unknown), A de Torrenté, Marta Waliszewska‐Prosół, Uwe Reuter	24
7	European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure 2022 ·The Journal of Headache and Pain ·Simona Sacco, Christian Lampl, Faisal Mohammad Amin, Mark Braschinsky, Christina Deligianni, Derya Uludüz, Jan Versijpt, Anne Ducros, Raquel Gil‐Gouveia, Zaza Katsarava, Paolo Martelletti, Raffaele Ornello, Bianca Raffaelli, Deirdre M. Boucherie, Patricia Pozo‐Rosich, Margarita Sánchez del Río, Alexandra J. Sinclair, Antoinette MaassenVanDenBrink, Uwe Reuter	47
8	The Effect of tRNA[Ser]Sec Isopentenylation on Selenoprotein Expression 2021 ·International Journal of Molecular Sciences ·Noelia Fradejas‐Villar, (unknown), Wenchao Zhao, Uwe Reuter, Annika Kötter, Mark Helm, Rainer Knoll, Robert McFarland, Robert W. Taylor, (unknown), Kenjyo Miyauchi, Yuriko Sakaguchi, Tsutomu Suzuki, Ulrich Schweizer	11
9	Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies 2021 ·Cephalalgia ·Richard B. Lipton, David W. Dodick, David Kudrow, Uwe Reuter, Nadia Tenenbaum, Feng Zhang, Gabriel Paiva da Silva Lima, Denise E. Chou, Daniel D. Mikol	4
10	Data Science in Economics: Comprehensive Review of Advanced Machine Learning and Deep Learning Methods 2020 ·Mathematics ·Saeed Nosratabadi, Amirhosein Mosavi, Puhong Duan, Pedram Ghamisi, Ferdinánd Filip, Shahab S. Band, Uwe Reuter, João Gama, Amir H. Gandomi	98
11	Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review 2020 ·Advances in Therapy ·Élizabeth Leroux, Andrew Buchanan, Louise Lombard, Li Shen Loo, (unknown), (unknown), (unknown), Brandy R. Matthews, Uwe Reuter	39
12	Smart Structural Health Monitoring of Flexible Pavements Using Machine Learning Methods 2020 ·Coatings ·Nader Karballaeezadeh, Danial Mohammadzadeh S., (unknown), (unknown), Amir Mosavi, Uwe Reuter	33
13	COVID-19 Outbreak Prediction with Machine Learning 2020 ·Algorithms ·Sina Ardabili, Amir Mosavi, Pedram Ghamisi, Ferdinánd Filip, Annamária R. Várkonyi-Kóczy, Uwe Reuter, Timon Rabczuk, Peter M. Atkinson	212
14	Long-term efficacy of erenumab in patients with episodic migraine who have failed prior preventive migraine therapies 2019 ·European Journal of Neurology ·Uwe Reuter, Todd J. Schwedt, David Kudrow, Koen Paemeleire, (unknown), Jan Klatt, Hernàn Picard, Denise E. Chou, (unknown)	2
15	Erarbeitung der Grundlagen für die Auslegung von Hochdruckpumpen bis 3000 bar 2017 ·RWTH Publications (RWTH Aachen) ·(unknown), (unknown), (unknown), Uwe Reuter, (unknown), Claudio P. Longo, Hubertus Murrenhoff, (unknown)	0
16	Headache and pregnancy: a systematic review 2017 ·The Journal of Headache and Pain ·Andrea Negro, (unknown), T. A. Ivanova, Sabrina Khan, Raffaele Ornello, Bianca Raffaelli, Alberto Terrin, Uwe Reuter, Dimos D. Mitsikostas	136
17	Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): A randomised controlled study 2015 ·Cephalalgia ·Charly Gaul, Hans‐Christoph Diener, Nicholas Silver, Delphine Magis, Uwe Reuter, (unknown), Eric Liebler, Andreas Straube, (unknown)	198
18	The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine 2014 ·Therapeutic Advances in Neurological Disorders ·Uwe Reuter, Heike Israel, Lars Neeb	34
19	Triptans Reduce the Inflammatory Response in Bacterial Meningitis 2002 ·Journal of Cerebral Blood Flow & Metabolism ·Olaf Hoffmann, (unknown), (unknown), Uwe Reuter, Klemens Angstwurm, Ralf R. Schumann, Ulrich Dirnagl, Joerg R. Weber	42
20	A "giant" prolactinoma 1997 ·Journal of Neurology Neurosurgery & Psychiatry ·Uwe Reuter, S. Mehraein, G. Arnold, R. Lehmann	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact